NCT04903548View on ClinicalTrials.gov

Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC with Y90 SIR-Spheres

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

January 8, 2021

Primary Completion Date

October 18, 2024

Study Completion Date

October 18, 2024

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

SIRT with Y-90 resin microspheres

Selective internal radiation therapy (SIRT) with Y-90 resin microspheres (Y-90 resin SIRT) is an intra-arterial, catheter-based locoregional therapy that has been used to treat patients with unresectable HCC

Trial Locations (1)

75203

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER

NCT04903548 - Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC with Y90 SIR-Spheres | Biotech Hunter | Biotech Hunter